Atheln, Inc. vs Fortrea

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/athelnbiomed/fortrea

Category	Atheln, Inc.	Fortrea
Listed site	cro	cro
Summary	Atheln provides customized strategic and operational consulting across product development, CMC, nonclinical, clinical, regulatory, and commercial services for pharma, biotech, and medtech clients.	Fortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success.
Services	Analytical Method Development & Validation Regulatory Affairs US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy Clinical Operations Medical Writing Translational Research China NMPA Regulatory Strategy Clinical Trial Services Biostatistics & Statistical Programming	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Clinical Trial Services Data Management & eClinical Biostatistics & Statistical Programming Medical Writing Pharmacovigilance & Drug Safety Regulatory Affairs Central Laboratory Services US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy Clinical Imaging Core Lab
Modalities	Small Molecule Biologics (Other) Oligonucleotide Peptide Radiopharmaceutical	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy Vaccine
Indications	Ophthalmology	Cardiovascular Metabolic Dermatology Infectious Disease Immunology Nephrology Neurology Oncology Ophthalmology Rare Disease Respiratory Women's Health Gastroenterology
Locations	Data not yet provided.	Global operations, United States Headquarters, Durham, NC, United States Dallas, Dallas, TX, United States Daytona Beach, Daytona Beach, FL, United States Madison, Madison, WI, United States Sydney, Sydney, NSW, Australia Beijing, Beijing, China Chengdu, Chengdu, Sichuan, China Dalian, Dalian, Liaoning, China Guangzhou, Guangzhou, China Hangzhou, Hangzhou, Zhejiang, China Hong Kong, Hong Kong, China Nanjing, Nanjing, Jiangsu, China Shanghai, Shanghai, China Seoul, Seoul, South Korea Taipei, Taipei, Taiwan Tokyo, Tokyo, Japan Raanana, Raanana, Israel Istanbul, Istanbul, Turkey Bogotá, Bogotá, Colombia Buenos Aires, Buenos Aires, Argentina Lima, Lima, Peru Mexico City, Mexico City, CDMX, Mexico Santiago, Santiago, Chile São Paulo, São Paulo, SP, Brazil Centurion, Centurion, Gauteng, South Africa Clinical Research Unit, Dallas, TX, United States Clinical Research Unit, Daytona Beach, FL, United States Clinical Research Unit, Madison, WI, United States Office, São Paulo, SP, Brazil Office, Mexico City, CDMX, Mexico Office, Buenos Aires, Argentina Office, Santiago, Chile Office, Lima, Peru Office, Bogotá, Colombia Office, Centurion, Gauteng, South Africa Office, Sydney, NSW, Australia Office, Beijing, China Office, Shanghai, China Office, Guangzhou, China Office, Chengdu, Sichuan, China Office, Dalian, Liaoning, China Office, Hangzhou, Zhejiang, China Office, Nanjing, Jiangsu, China Office, Hong Kong, China Office, Tokyo, Japan Office, Seoul, South Korea Office, Taipei, Taiwan Office, Raanana, Israel Office, Istanbul, Turkey Office, Herzliya, Israel Herzliya, Raanana, Israel Herzliya, Herzliya, Israel Office, Hong Kong, Hong Kong
Certifications	Data not yet provided.	cGMP · Identifier: In-clinic cGMP Pharmacies FDA · Identifier: cGMP
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.